EDSA: Edesa Biotech, Inc. Company Short-Term Debt

Symbol and logo of brand Edesa Biotech, Inc. (EDSA)

Monitoring the short-term liabilities of Edesa Biotech, Inc. (EDSA) helps assess financial stability regarding ARDS treatment, where revenue is based on government procurement. The 0.00 level captures the current state of debt while the dermatology staff develops projects through option programs. Finally, the active rollout of Phase III monoclonal antibody trials confirms a high concentration of resources within the R&D pipeline.

EDSA (Edesa Biotech Inc) Company Short-Term Debts history from 07/04/2022 to 10/29/2026

Metric breakdowns and analytics for Edesa Biotech Corp (EDSA)

- current quotes and average value forecast:
Price Chart Edesa Biotech|EDSA - Fair Value Consensus
- market capitalization information:
Market Value Edesa Biotech, Inc.|EDSA - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Edesa Biotech|EDSA - Book Capitalization|Market Cap to Net Assets Ratio edesabiotech.com|EDSA - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Edesa Biotech, Inc.|EDSA - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Edesa Biotech, Inc.|EDSA - Company Total Debt|Debt to Book Capitalization Ratio Edesa Biotech, Inc.|EDSA - Company Long-Term Liabilities|Company Current Liabilities Edesa Biotech
Initial company analysis:EDSA - Edesa Biotech
Manufactured products of Edesa Biotech, Inc.

Investors must determine whether potential returns outweigh the risk of a sudden loss of liquidity due to urgent obligations. By analyzing short-term accounts payable, one can assess the volume of loan payments, where debt reduction eases the interest burden but limits the cash necessary for Edesa Biotech, Inc. (EDSA) to maintain strict ESG standards and environmental compliance within its biopharmaceutical laboratories.

Competitor analysis

ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|Upstream Bio Corp - Company Short-Term Debts|Short-Term Debt Zenas Corp|IMNM: Company Short-Term Debts|Company Short-Term Indebtedness GOSS|KALV (KalVista Pharmaceuticals, Inc.) - Company Short-Term Debts|Short-Term Debt Septerna, Inc. SEPN|Company Short-Term Debt Pieris Pharmaceuticals Inc (PVLA)|Short-Term Debt Volume Savara Pharma|Company Short-Term Debts RIGL (Rigel Pharmaceuticals)|Company Short-Term Debts anaptysbio.com ANAB|ATXS: Company Current Liabilities|Company Short-Term Loans and Borrowings ENGN (enGene Holdings Inc)|RAPT: Company Short-Term Debts|JBIO (Aerovate Therapeutics) - Company Short-Term Debt|ACRS (Aclaris Therapeutics) - Company Short-Term Debts|kyvernatx.com (KYTX) - Short-Term Debt Volume|Company Short-Term Debt Tiziana Life Sciences Ltd (TLSA)|CABA - Short-Term Debt|Ventyx Bio - Company Current Liabilities|Amount of Current Liabilities THTX (Theratechnologies, Inc)|Avalo Therapeutics, Inc - Company Short-Term Debts|Short-Term Debt eledon.com|AGEN: Company Short-Term Debts|Company Current Liabilities Climb Bio Inc.|ZURA (Zura Bio) - Company Short-Term Debts|ATYR: Company Short-Term Loans and Borrowings|Company Current Liabilities ADAG (Adagene)|IMA (ikenaoncology.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts STTK (Shattuck Labs)|Short-Term Debt Volume Equillium Inc (EQ)|CNTB - Company Short-Term Debt|IMUX (Immunic, Inc.) - Company Short-Term Indebtedness|ATRA: Company Short-Term Debts|Company Current Liabilities InflaRx|Company Current Liabilities XFOR|Adicet (ACET) - Short-Term Debt Volume|Company Short-Term Debts CELU|INMB - Short-Term Debt|Company Short-Term Debts BRNS (Barinthus Biotherapeutics)|KZR: Company Short-Term Indebtedness|SABS - Company Short-Term Debt|Short-Term Debt Volume Akari Therapeutics PLC AKTX|ENLV: Company Short-Term Debts|Q32 Bio (QTTB) - Company Short-Term Debts|Company Short-Term Debt GeoVax Labs, Inc.|ibioinc.com - Current Liabilities|Company Short-Term Debts CARM|XTLB (XTL Biopharmaceuticals Ltd) - Company Short-Term Loans and Borrowings|Company Short-Term Debts BOLT (Bolt Biotherapeutics, Inc.)|Company Short-Term Debts HCW Biologics, Inc. HCWB|APVO - Company Short-Term Debt|Company Short-Term Loans and Borrowings AIM (aimimmuno.com)|aditxt.com (ADTX) - Company Short-Term Debt|Company Current Liabilities GRI Bio Inc|XRTX (XORTX) - Company Short-Term Debts|Company Short-Term Debts Vyome Therapeutics|Company Current Liabilities REVB (Revelation Biosciences)|INDP (indaptusrx.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts SCNI (Scinai Immunotherapeutics Ltd.)|Short-Term Debt Volume CalciMedica Inc (CALI)|AFMD - Company Short-Term Debt|Allakos Inc. (ALLK) - Company Current Liabilities|hookipapharma.com (HOOK) - Company Short-Term Debt|Company Current Liabilities IGM Biosciences|Company Current Liabilities ITOS|Company Short-Term Debts Ocean Biomedical Inc|Company Short-Term Debt TC BioPharm (Holdings) PLC (TCBP)|Third Harmonic Bio Inc - Company Short-Term Indebtedness